Starting in August, the National Health Insurance (NHI) system would cover a drug for spinal muscular atrophy (SMA) for infants under six months old, National Health Insurance Administration (NHIA) Deputy Director-General Tsai Shu-ling (蔡淑鈴) said.
SMA is a rare neuromuscular genetic disease that affects the central nervous system, peripheral nervous system and voluntary muscle movements in patients, which results in degeneration of muscles in limbs and respiratory organs.
The one-time gene therapy drug, sold under the brand name Zolgensma, has a list price of US$2.1 million in the US.
Photo: Taipei Times file
However, the NHIA has negotiated the price down to NT$49 million (US$1.58 million) per dose, Tsai said.
It would be the first time the NHI has covered a gene therapy, Tsai said.
About eight children in Taiwan would benefit from the new policy every year, she said.
While the drug has proven effective among patients over a broader age range and has lifelong effects, its prohibitive cost has led the NHIA to initially make it only available for infants aged up to six months old, who have shown the most promising response to treatment, Tsai said.
However, she said it is difficult to guarantee that the medicine would have “lifelong” effects, as it is a new drug and follow-up checks with patients have been conducted for only the past eight years.
The NHIA would track the progress of Taiwanese who receive the drug and review cases from other countries to determine whether coverage should be expanded to other age groups, Tsai said.
Other SMA treatments include a spinal injection called Spinraza and a liquid oral medication called Evrysdi, both of which are covered by the NHI for children aged up to three years old, she said.
Patients older than three have to undergo revised upper limb module assessment, a test designed to determine the upper limb functions in SMA patients to see whether they are eligible for therapies covered by the NHI system, she added.
Tsai said she hopes the NHI’s coverage of therapies for the condition would benefit at least half of the 400 people with SMA in Taiwan.
Foreign tourists who purchase a seven-day Taiwan Pass are to get a second one free of charge as part of a government bid to boost tourism, the Tourism Administration said yesterday. A pair of Taiwan Passes is priced at NT$5,000 (US$156.44), an agency staff member said, adding that the passes can be used separately. The pass can be used in many of Taiwan’s major cities and to travel to several tourist resorts. It expires seven days after it is first used. The pass is a three-in-one package covering the high-speed rail system, mass rapid transport (MRT) services and the Taiwan Tourist Shuttle services,
Drinking a lot of water or milk would not help a person who has ingested terbufos, a toxic chemical that has been identified as the likely cause of three deaths, a health expert said yesterday. An 83-year-old woman surnamed Tseng (曾) and two others died this week after eating millet dumplings with snails that Tseng had made. Tseng died on Tuesday and others ate the leftovers when they went to her home to mourn her death that evening. Twelve people became ill after eating the dumplings following Tseng’s death. Their symptoms included vomiting and convulsions. Six were hospitalized, with two of them
DIVA-READY: The city’s deadline for the repairs is one day before pop star Jody Chiang is to perform at the Taipei Dome for the city’s Double Ten National Day celebrations The Taipei City Government has asked Farglory Group (遠雄集團) to repair serious water leaks in the Taipei Dome before Friday next week, Taipei Mayor Chiang Wan-an (蔣萬安) said yesterday, following complaints that many areas at the stadium were leaking during two baseball games over the weekend. The dome on Saturday and Sunday hosted two games in tribute to CTBC Brothers’ star Chou Szu-chi (周思齊) ahead of his retirement from the CPBL. The games each attracted about 40,000 people, filling the stadium to capacity. However, amid heavy rain, many people reported water leaking on some seats, at the entrance and exit areas, and the
BIG collection: The herbarium holds more than 560,000 specimens, from the Japanese colonial period to the present, including the Wulai azalea, which is now extinct in the wild The largest collection of plant specimens in Taiwan, the Taipei Botanical Garden’s herbarium, is celebrating its 100th anniversary with an exhibition that opened on Friday. The herbarium provides critical historical documents for botanists and is the first of its kind in Taiwan, Taiwan Forestry Research Institute director Tseng Yen-hsueh (曾彥學) said. It is housed in a two-story red brick building, which opened during 1924. At the time, it stored 30,000 plant specimens from almost 6,000 species, including Taiwanese plant samples collected by Tomitaro Makino, the “father of Japanese botany,” Tseng said. The herbarium collection has grown in the century since its